CLINICAL_TRIALS
withdrawal
· 2014-11-21
Clinical Trial Update: The Effectiveness of Lower Cyclosporine Doses for Psoriasis [Phase 2]
Summary
A Phase 2 trial evaluating lower doses of cyclosporine for psoriasis has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Rochester | Conditions: Psoriasis | Phase 2 | Status: WITHDRAWN